AZN vs XPON · P/E 28, $288.38B cap vs rev $9.7M
AstraZeneca PLC (AZN) versus Expion360 Inc (XPON) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Expion360 Inc (XPON) is a electrical equipment & parts company listed on NASDAQ.
AZN does not have a complete income-statement cache yet.
Latest reported XPON revenue for 2025-12-31 was $9.7M. Net income was -$6.2M. Revenue was up 71.6% from 2024-12-31 to 2025-12-31. XPON currently screens at market cap $5.5M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. XPON currently screens at market cap $5.5M.
Not investment advice. Open the AZN and XPON stock pages for the full models.
Not investment advice.